In 2016 Hemofarm is planning to open facility for quality control and new products launch


During this year, Hemofarm maintained record in production of 4 billion tablets. The company also reached the status of benefited entity at the customs, opened new ampules production department, passed strict control of domestic controls and was graded with five for sustainable business.
- Numbers are
important indicator of our success but I always outline there is something more
important – people. Therefore in the
future we will continue to develop portfolio in line with world trends and needs of patients as well. Together
with Hemofarm Foundation which is a partner with the Ministry of Heath, we are
continuing the struggle for better picture of health system of Serbia, for
health for each one of us - Ronald
Seeliger, GM at Hemofarm, said.
In the year of jubilee - 55 years of operations, Hemofarm received three significant awards: the first national award "VIRTUS" for corporate philanthropy, "Top Serbian Brands" awards and a special awards for Health and Safety at work from the Ministry for labor, employment, social and veteran issues.
